- UK jobs market slowed again in November before budget, survey shows Reuters
- Bank of England: Businesses cut staff at fastest pace since pandemic City AM
- Businesses slashed jobs at fastest rate in four years ahead of Budget The Telegraph
- Business…
Category: 6. Business
-
UK jobs market slowed again in November before budget, survey shows – Reuters
-
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that…
Continue Reading
-
OpenAI goes from stock market savior to burden as AI risks mount
Wall Street’s sentiment toward companies associated with artificial intelligence is shifting, and it’s all about two companies: OpenAI is down, and Alphabet Inc. is up.
The maker of ChatGPT is no longer seen as being on the cutting edge of AI…
Continue Reading
-
Institutional owners may consider drastic measures as CAR Group Limited’s (ASX:CAR) recent AU$814m drop adds to long-term losses
-
Given the large stake in the stock by institutions, CAR Group’s stock price might be vulnerable to their trading decisions
-
A total of 25 investors have a majority stake in the company with 50% ownership
-
Analyst forecasts along with…
Continue Reading
-
-
BRUIN Final Analysis: Pirtobrutinib Durable in Post-Covalent BTK CLL/SLL | Targeted Oncology
The noncovalent Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib (Jaypirca) elicited objective response rate (ORR) of 81.6% (95% CI, 76.5%–85.9%) in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)…
Continue Reading
-
“Smart” Strategy of Up-front Targeted Therapy Reduces Need for Chemo in LBCL
More than half of patients with newly diagnosed large B-cell lymphoma (LBCL) may reduce or remove chemotherapy with a targeted therapy–first strategy, according to data from the primary analysis of the Smart Stop trial (NCT04978584) presented…
Continue Reading
-
Owning 36% in Magnetic Resources NL (ASX:MAU) means that insiders are heavily invested in the company’s future
-
Significant insider control over Magnetic Resources implies vested interests in company growth
-
51% of the business is held by the top 8 shareholders
-
Past performance of a company along with ownership data serve to give a strong idea…
Continue Reading
-
-
HP’s chief commercial officer predicts the future will include AI PCs that don’t use the cloud
Increased focus on “privacy and security” may open the door for AI-enabled devices rather than rely entirely on cloud computing and remote data centers.
“In a world where sovereign data retention matters, people want to know that if they…
Continue Reading
-
Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib) – Eli Lilly and Company
- Lilly’s Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib) Eli Lilly and Company
- At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma Yahoo Finance
- U.S….
Continue Reading
-
Assessing Valuation After Steady Earnings Growth and Weak One-Year Share Price Returns
Kenvue (KVUE) keeps drifting lower even after reporting steady revenue and profit growth, which raises a simple question for investors: is the market underpricing a slow but dependable consumer health story?
See our latest analysis for…
Continue Reading